Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bital Savir-Baruch

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
AJR. American Journal of Roentgenology|May 15, 2024
Beyond the <i>AJR</i>: PET/MRI Using <sup>68</sup>Ga-RM2 Has Superior Performance to MRI Alone in the Localization of Lesions in Patients With Biochemical Failure After Prostate Cancer TreatmentBital Savir-Baruch, Ephraim Parent
PET Clinics|October 13, 2022
Prostate Cancer Imaging with 18F-FluciclovineBital Savir-Baruch, David M Schuster
The Urologic Clinics of North America|July 23, 2018
Imaging of Prostate Cancer Using FluciclovineBital Savir-Baruch, Lucia Zanoni, David M Schuster
PET Clinics|March 8, 2017
Imaging of Prostate Cancer Using FluciclovineBital Savir-Baruch, Lucia Zanoni, David M Schuster
Urologic Oncology|April 30, 2023
Impact of <sup>18</sup>F-fluciclovine PET/CT on plans for androgen deprivation therapy in patients with biochemical recurrence of prostate cancer: data analysis from two prospective clinical trialsGerald L Andriole, Andrew F Scarsbrook, Bital Savir-Baruch, et al.
AJR. American Journal of Roentgenology|February 22, 2021
Using <sup>18</sup>F-Fluciclovine PET/CT to Detect Prostate Cancer Recurrence in Patients With Very Low PSA LevelsBarry A Siegel, David M Schuster, Bital Savir-Baruch
Radiologic Clinics of North America|August 16, 2021
PET Imaging for Prostate CancerBital Savir-Baruch, Rudolf A Werner, Steven P Rowe, et al.
Journal of Nuclear Medicine Technology|October 13, 2019
Characterizing and Mitigating Bladder Radioactivity on <sup>18</sup>F-Fluciclovine PET/CTPetra Lovrec, David M Schuster, Robert H Wagner, et al.
Journal of Nuclear Medicine Technology|June 12, 2019
Best Practices for <sup>18</sup>F-Fluciclovine PET/CT Imaging of Recurrent Prostate Cancer: A Guide for TechnologistsFunmilayo I Tade, Rebecca A Sajdak, Mehdat Gabriel, et al.
Journal of Nuclear Medicine Technology|September 28, 2012
Development of a relational database to capture and merge clinical history with the quantitative results of radionuclide renographyRussell D Folks, Bital Savir-Baruch, Ernest V Garcia, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
AJR. American Journal of Roentgenology|May 15, 2024
Beyond the <i>AJR</i>: PET/MRI Using <sup>68</sup>Ga-RM2 Has Superior Performance to MRI Alone in the Localization of Lesions in Patients With Biochemical Failure After Prostate Cancer TreatmentBital Savir-Baruch, Ephraim Parent
PET Clinics|October 13, 2022
Prostate Cancer Imaging with 18F-FluciclovineBital Savir-Baruch, David M Schuster
The Urologic Clinics of North America|July 23, 2018
Imaging of Prostate Cancer Using FluciclovineBital Savir-Baruch, Lucia Zanoni, David M Schuster
PET Clinics|March 8, 2017
Imaging of Prostate Cancer Using FluciclovineBital Savir-Baruch, Lucia Zanoni, David M Schuster
Urologic Oncology|April 30, 2023
Impact of <sup>18</sup>F-fluciclovine PET/CT on plans for androgen deprivation therapy in patients with biochemical recurrence of prostate cancer: data analysis from two prospective clinical trialsGerald L Andriole, Andrew F Scarsbrook, Bital Savir-Baruch, et al.
AJR. American Journal of Roentgenology|February 22, 2021
Using <sup>18</sup>F-Fluciclovine PET/CT to Detect Prostate Cancer Recurrence in Patients With Very Low PSA LevelsBarry A Siegel, David M Schuster, Bital Savir-Baruch
Radiologic Clinics of North America|August 16, 2021
PET Imaging for Prostate CancerBital Savir-Baruch, Rudolf A Werner, Steven P Rowe, et al.
Journal of Nuclear Medicine Technology|October 13, 2019
Characterizing and Mitigating Bladder Radioactivity on <sup>18</sup>F-Fluciclovine PET/CTPetra Lovrec, David M Schuster, Robert H Wagner, et al.
Journal of Nuclear Medicine Technology|June 12, 2019
Best Practices for <sup>18</sup>F-Fluciclovine PET/CT Imaging of Recurrent Prostate Cancer: A Guide for TechnologistsFunmilayo I Tade, Rebecca A Sajdak, Mehdat Gabriel, et al.
Journal of Nuclear Medicine Technology|September 28, 2012
Development of a relational database to capture and merge clinical history with the quantitative results of radionuclide renographyRussell D Folks, Bital Savir-Baruch, Ernest V Garcia, et al.
Pageof 5